(“Mandarin”). This transaction is classified as the connected transaction with the following details: The transaction date : After the approval from the Board of Directors’ meeting. The connected parties
businesses and investors, preparing a set of common offering rules classified by risk and complexity levels of products to boost flexibility in offering new products and services, and introducing a new
% 51.41 63.64% 4. Livestock 11.47 3.62% 9.27 2.50% (2.20) (19.18%) Total Sales revenues 316.83 100.00% 371.33 100.00% 54.50 17.20% Such growth was driven by a surge in revenues from sales of companion
www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th a surge in revenues from sales of
administrative expenses for the three months period ended 31 March 2018 and 2019 at THB 34.11 million and THB 40.14 million respectively. This equals to a surge of 17.68 % in administrative expenses year on year
& expenses (net of tax) from the comparing quarters, the normalized net profit would be approximately THB 72.8 million in 2Q19 comparing to THB 52.4 million in 2Q18 or a surge of 39% . Statement of Financial
. Tambon Tarsit, Amohoe Pluag-daeng, Rayong As of June 30, 2018 the Company and its subsidiary had a significant surge in trade and other receivables when compared to last year which was mainly from an
standard (including interbank and money market items) amounted to Baht 194,135.8 million, increased by Baht 35.5 million when compared to the end of 2020. Loans to Customers Classified by Business Sector
million, and (6) increase in other revenue by 2.43 million. In the first quarter of 2022, sales revenue increased by THB 757.80 million. This surge was primarily driven by Branch and Online sales, a result